AUTHOR=Treon Steven P. , Kotton Camille N. , Park David J. , Moranzoni Giorgia , Lemvigh Camilla K. , Gathe Joseph C. , Varughese Tilly A. , Barnett Christopher F. , Belenchia Johnny M. , Clark Nina M. , Farber Charles M. , Abid Muhammad Bilal , Ahmed Gulrayz , Patterson Christopher J. , Guerrera Maria L. , Soumerai Jacob D. , Chea Vipheaviny A. , Carulli Isabel P. , Southard Jackson , Li Shuqiang , Wu Catherine J. , Livak Kenneth J. , Holmgren Eric , Kim Pil , Shi Carrie , Lin Holly , Ramakrishnan Vanitha , Ou Ying , Olszewski Scott , Olsen Lars Rønn , Keskin Derin B. , Hunter Zachary R. , Tankersley Christopher , Zimmerman Todd , Dhakal Binod 

TITLE=A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings

JOURNAL=Frontiers in Immunology

VOLUME=15

YEAR=2025

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1369619

DOI=10.3389/fimmu.2024.1369619

ISSN=1664-3224